Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

• HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
• Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
• Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
• Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
• A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
• A Safety Study of SGN-CD19A for B-Cell Lymphoma
• A Safety Study of SGN-CD19A for Leukemia and Lymphoma
• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
• Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Acute Lymphoblastic Leukemia
• Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
• Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia